Table 3 from The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
Overview of SAEs reported during the study and assessed as related to TempoCure, WBHT, or their combination, categorized by severity (CTCAE v5.0).
创建时间：
2026-02-04
